Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)
Clinical trial NCT02107898 · COMPLETED
Trial details
- NCT number
- NCT02107898
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-01-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.